AIDS News and Research

RSS

South African sales of MedMira rapid HIV tests begin

MedMira Inc., the international market leader in rapid flow- through diagnostic technology announced today that it has begun shipment of its MiraWell(TM) Rapid HIV Test to its distributor.

26 Sep 2004

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Researchers targeted Nef, a protein responsible for accelerating the development of acquired immunodeficiency syndrome, or AIDS. Nef was targeted with small molecules synthesized by the researchers – molecules that disrupted Nef’s interaction with other proteins.

26 Sep 2004

Asia must tackle HIV in injecting drug users

Asian countries must adopt strategies to slow the spread of HIV among injecting drug users, urge researchers in this week's BMJ.

23 Sep 2004

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Dr Norelle Daly, from UQ’s Institute for Molecular Bioscience, is looking at the molecular structure of retrocyclin, a molecule with the ability to protect human cells from HIV infection.

23 Sep 2004

PAHO aids relief efforts in Caribbean

Disaster experts from the Pan American Health Organization (PAHO) are working with other international and local agencies to carry out relief efforts in nine Caribbean countries affected by hurricanes and tropical storms

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Glaxo drops appeal in AIDS drug pricing case

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward.

22 Sep 2004

Edible vaccine for HIV AIDS

Scientists from Novosibirsk are engaged in the development of an unusual vaccine which, apart from being less expensive to produce, safe and painless to administer, is also edible.

22 Sep 2004

NIH opens new hospital totally dedicated to clinical research

This new hospital totally dedicated to clinical research — research involving patients — is the most significant addition to the NIH campus in more than 50 years and provides a unique opportunity for scientists, clinicians, and patients to study and conquer both chronic and acute disease in the 21st century.

22 Sep 2004

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Challenging the notion that multidrug-resistant tuberculosis (MDR-TB) poses a low threat to populations, epidemiologists at the Harvard School of Public Health (HSPH) have constructed a mathematical model of the disease variant's potential course

20 Sep 2004

Disabled people need better specialist equipment

For many disabled people, assistive technology is crucial to their ability to choose how they want to live and whether they can live independently.

20 Sep 2004

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Urgent measures need to be taken to protect the public from contaminated blood transfusions

In the Western Pacific Region, transmission of HIV/AIDS and other infections such as hepatitis B and C through blood transfusion remains a serious threat. It is particularly acute in areas where prevalence of these diseases is high and access to safe blood is limited.

16 Sep 2004

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Dr Shigeru Omi, World Health Organization Regional Director for the Western Pacific, has warned of the danger of HIV "bridging" into the general population from infected individuals with high-risk behaviour unless countries and areas in the Region act now to avoid a major HIV/AIDS epidemic.

16 Sep 2004

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Republican and Democratic presidential campaign representatives today said their candidates will address the public health work force shortage, but they debated the need for sex education and federal regulation of tobacco

16 Sep 2004

Protein that causes juvenile Batten disease also plays a key role in normal cell function

The aberrant protein that causes juvenile Batten disease, a fatal neurodegenerative disorder of childhood, also plays a key role in normal cell function, Duke University Medical Center researchers have found.

16 Sep 2004

Experts discuss antibiotic resistance, tuberculosis, malaria, vaccines, maternal mortality, childhood diseases and health sector reform

New challenges ahead and the unfinished agenda in public health in the Americas" will be the focus of joint efforts by the Pan American Health Organization (PAHO) and the U.S. Agency for International Development (USAID)

14 Sep 2004

Early use of combination-drug treatments could improve HIV survival rates

Survival rates of HIV-positive patients could be improved if combination-drug treatment were begun earlier than current clinical guidelines now recommend, according to a new study by researchers from The New York Academy of Medicine and the Johns Hopkins University Bloomberg School of Public Health.

14 Sep 2004

Bush AIDS plan is using expensive, brand name drugs, rather than keeping its promise to use the lowest cost drugs available

Global AIDS Alliance reacted today to the statement of the Bush Administration regarding its global AIDS programs.

14 Sep 2004

California Chamber of Commerce lends support to stem cell research

The California Chamber of Commerce has joined with a broad and growing coalition of business groups, patient advocates and medical organizations in endorsing a "YES" vote on Proposition 71, the California Stem Cell Research and Cures Initiative, on the November 2004 statewide ballot.

14 Sep 2004

AIDS News and Research

South African sales of MedMira rapid HIV tests begin

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Asia must tackle HIV in injecting drug users

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

PAHO aids relief efforts in Caribbean

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Glaxo drops appeal in AIDS drug pricing case

Edible vaccine for HIV AIDS

NIH opens new hospital totally dedicated to clinical research

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Disabled people need better specialist equipment

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Urgent measures need to be taken to protect the public from contaminated blood transfusions

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Protein that causes juvenile Batten disease also plays a key role in normal cell function

Experts discuss antibiotic resistance, tuberculosis, malaria, vaccines, maternal mortality, childhood diseases and health sector reform

Early use of combination-drug treatments could improve HIV survival rates

Bush AIDS plan is using expensive, brand name drugs, rather than keeping its promise to use the lowest cost drugs available

California Chamber of Commerce lends support to stem cell research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News